We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cybin Inc | AMEX:CYBN | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.0077 | 2.25% | 0.35 | 0.35 | 0.337 | 0.34 | 2,912,254 | 00:56:04 |
TORONTO, Canada -- January 27, 2022 -- InvestorsHub NewsWire -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to Therapeutics™" today announced that it will report financial results for its third quarter ended December 31, 2021 on Thursday, February 10, 2022.
A conference call will be held on the same day at 8:30 a.m. (EST) to discuss the results and recent business updates. The call will be hosted by Doug Drysdale, Cybin's Chief Executive Officer. Mr. Drysdale and other members of the management team will be available to answer questions from participants following the prepared remarks.
CONFERENCE CALL DETAILS:
DATE: |
Thursday, February 10, 2022 |
|
TIME: |
8:30 a.m. (EST) |
|
DIAL-IN |
1-844-200-6205 (U.S. toll free) or 1-833-950-0062 (Canada toll free) |
|
CODE |
868712 |
|
WEBCAST |
An archived webcast will also be available on the Company's Investor Relations site under the Events & Presentations page.
About Cybin
Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.
Investors & Media:
Leah Gibson
Vice President, Investor Relations
Cybin Inc.
leah@cybin.com
1 Year Cybin Chart |
1 Month Cybin Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions